Us Bancorp \De\ Bio Xcel Therapeutics, Inc. Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 18,033 shares of BTAI stock, worth $9,196. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,033

Previous 18,468 2.36%

Holding current value

$9,196

Previous $23,000 52.17%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$0.53 - $1.34 $230 - $582	-435 Reduced 2.36%	18,033 $11,000
Q2 2024 Aug 06, 2024	BUY	$1.14 - $2.97 $495 - $1,291	435 Added 2.41%	18,468 $23,000
Q3 2023 Nov 03, 2023	BUY	$2.49 - $11.85 $9,862 - $46,937	3,961 Added 28.15%	18,033 $45,000
Q2 2023 Aug 09, 2023	BUY	$6.39 - $28.58 $89,709 - $401,234	14,039 Added 42542.42%	14,072 $93,000
Q4 2022 Feb 13, 2023	SELL	$10.25 - $22.43 $3,915 - $8,568	-382 Reduced 92.05%	33 $0
Q3 2022 Oct 27, 2022	SELL	$11.19 - $17.89 $2,193 - $3,506	-196 Reduced 32.08%	415 $5,000
Q2 2022 Aug 01, 2022	SELL	$9.03 - $21.55 $957 - $2,284	-106 Reduced 14.78%	611 $8,000
Q1 2022 May 11, 2022	SELL	$15.0 - $22.83 $1,650 - $2,511	-110 Reduced 13.3%	717 $15,000
Q4 2021 Feb 11, 2022	SELL	$20.12 - $35.09 $4,486 - $7,825	-223 Reduced 21.24%	827 $17,000
Q3 2021 Nov 10, 2021	SELL	$23.84 - $32.03 $8,296 - $11,146	-348 Reduced 24.89%	1,050 $32,000
Q2 2021 Aug 05, 2021	SELL	$29.06 - $38.83 $102,233 - $136,603	-3,518 Reduced 71.56%	1,398 $41,000
Q1 2021 Apr 28, 2021	SELL	$39.04 - $64.6 $9,564 - $15,826	-245 Reduced 4.75%	4,916 $212,000
Q4 2020 Feb 04, 2021	BUY	$42.46 - $56.58 $15,795 - $21,047	372 Added 7.77%	5,161 $238,000
Q3 2020 Nov 10, 2020	BUY	$37.44 - $64.63 $91,840 - $158,537	2,453 Added 105.01%	4,789 $207,000
Q2 2020 Aug 07, 2020	SELL	$17.62 - $58.71 $12,193 - $40,627	-692 Reduced 22.85%	2,336 $124,000
Q1 2020 May 13, 2020	BUY	$12.26 - $41.14 $37,123 - $124,571	3,028 New	3,028 $68,000

Others Institutions Holding BTAI

# of Institutions

Shares Held

3.14M

Call Options Held

22.2K

Put Options Held

40.2K

View Full List

About BioXcel Therapeutics, Inc.

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $14.3M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

More about BTAI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account